A biological target is something among a living organism to that another entity is directed and/or binds, leading to a modification in its behavior or performs. The definition is context-dependent, and may consult with the biological target of a pharmacologically active drug compound, the receptor target of an internal secretion, or another target of associate external input. Biological targets area unit most typically proteins like enzymes, particle channels, and receptors. Drug target discovery, that involves the identification and early validation of disease-associated targets, is that the start within the drug discovery pipeline. Unwellness involves alterations in factor and/or super molecule expression and modification and therefore offers a basis for detection of drug targets through examining the factor or super molecule expression profiles. Altered proteins in disease are candidates of drug targets that can be validated by modulating the proteins activities in a model system to determine the outcome on disease phenotype.
Pharmacovigilance and Pharmacoepidemiology is a scholarly journal maintaining high standards of Pharmacoepidemiology Researches. This Journal runs with scientific excellence and propagates the peer review process very quickly. . Pharmacovigilance Journal is interested in the special fields related to the topics of this Journal.